Authors MF and NH were employees of Boehringer Ingelheim Pharma GmbH and Co. KG, Biberach, Germany, at the time of the research project. Author LK received research grants from Boehringer Ingelheim ...
As part of the investment, the company opened a biomass power plant in Ingelheim, Germany, in January this year, and completed the Biologicals Development Centre in Biberach last year. A chemical ...
Medigenomix is supporting operations of Boehringer Ingelheim's central DNA bank. Using a fully automated robot-based system many... Ebersberg/Biberach an der Riss, September 16, 2010. Boehringer ...